Immunoids: Building immunocompetent organoids from human pluripotent stem cells
vol.33 iss.10 (2026) pp.15 Clinical base editing for β-hemoglobinopathies across different genetic backgrounds
vol.33 iss.10 (2026) pp.13 Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease
vol.33 iss.10 (2026) pp.15 Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine
vol.33 iss.10 (2026) pp.18 Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease
vol.33 iss.10 (2026) pp.15 Endothelialized callus organoids drive rapid regeneration of critical-size segmental long bone defects
vol.33 iss.10 (2026) pp.18 Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases
vol.33 iss.10 (2026) pp.19 IGF2 acts downstream of Hippo signaling to regulate organ growth and restore liver regeneration in aging
vol.33 iss.10 (2026) pp.18 H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids
vol.33 iss.10 (2026) pp.20 Heart valves enter their organoid era
vol.33 iss.9 (2026) pp.2 APOE4 astrocytes call the shots on neuronal α-synuclein pathology
vol.33 iss.9 (2026) pp.3 Beyond compensation: Organized pathological hematopoiesis in the myelofibrotic spleen
vol.33 iss.9 (2026) pp.3 Feeling the tension: Engineered stem cells convert tumor stiffness into a drug target
vol.33 iss.9 (2026) pp.3 Ovarian aging and systemic health: Mechanisms and emerging intervention strategies
vol.33 iss.9 (2026) pp.18 Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types
vol.33 iss.9 (2026) pp.15 Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target
vol.33 iss.9 (2026) pp.18 Splenic extramedullary hematopoiesis in myelofibrosis is shaped by transcriptomic and epigenetic dysregulation
vol.33 iss.9 (2026) pp.19 Human iPSC-derived heart valve-like assembloids model valve development and disease pathology
vol.33 iss.9 (2026) pp.14 Human heart valve-like tissues from pluripotent stem cells with enhanced maturation recapitulate inflammatory valve disease
vol.33 iss.9 (2026) pp.12 Morphogen-guided neocortical organoids with anteroposterior areal identity
vol.33 iss.9 (2026) pp.13 TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation
vol.33 iss.9 (2026) pp.14 A Linc1405/Eomes Complex Promotes Cardiac Mesoderm Specification and Cardiogenesis
vol.33 iss.9 (2026) pp.1 “Heart-in-the-dish” models identify mechanisms of diastolic dysfunction
vol.33 iss.8 (2026) pp.3 The price of plasticity: Losing colon identity to gain metastatic potential
vol.33 iss.8 (2026) pp.3 Reconstructing primate gametogenesis along its developmental trajectory
vol.33 iss.8 (2026) pp.3 Mapping cell fate in space and time
vol.33 iss.8 (2026) pp.2 Living therapeutic depots: Matching design to therapeutic needs
vol.33 iss.8 (2026) pp.3 Dissecting divergent outcomes in stem cell-derived dopamine cell therapy trials for Parkinson’s disease
vol.33 iss.8 (2026) pp.13 Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis
vol.33 iss.8 (2026) pp.19 Generation of spermatogonia from human and non-human primate pluripotent stem cells
vol.33 iss.8 (2026) pp.15 Lineage plasticity driven by GATA6 loss fuels colorectal cancer metastasis
vol.33 iss.8 (2026) pp.20 Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
vol.33 iss.8 (2026) pp.15 Human iPSC-derived engineered heart tissue model of diastolic dysfunction in heart failure with preserved ejection fraction
vol.33 iss.8 (2026) pp.15 FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function
vol.33 iss.8 (2026) pp.9 Cardiopedia-Ligand: A ligand-receptor perturbation atlas of human cardiac organoid function and transcriptional state
vol.33 iss.8 (2026) pp.16 Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level
vol.33 iss.8 (2026) pp.19 SPACE-seq integrates spatial transcriptomics and lineage tracing in native tissues
vol.33 iss.8 (2026) pp.16 Evolving strategies for lineage tracing: Genetic markers, synthetic barcodes, and natural variants
vol.33 iss.7 (2026) pp.18 Designing complex organoids through developmental principles
vol.33 iss.7 (2026) pp.14 ENPP1 blockade with a humanized monoclonal antibody enhances renal repair after acute kidney injury
vol.33 iss.7 (2026) pp.17 Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment
vol.33 iss.7 (2026) pp.17 Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems
vol.33 iss.7 (2026) pp.17 Human retinal organoids functionally bridge a transected optic nerve in a rat model
vol.33 iss.7 (2026) pp.13 Generation of human appetite-regulating neurons and tanycytes from pluripotent stem cells
vol.33 iss.7 (2026) pp.17 ZNF512B safeguards genome integrity at regulatory regions to repress the SASP and inflammation
vol.33 iss.7 (2026) pp.14 Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation
vol.33 iss.7 (2026) pp.20 A precision product framework for context-dependent mechanisms of MSC therapy
vol.33 iss.6 (2026) pp.6 Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction
vol.33 iss.6 (2026) pp.17 Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation
vol.33 iss.6 (2026) pp.15 Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems
vol.33 iss.6 (2026) pp.19
vol.33 iss.10 (2026) pp.15 Clinical base editing for β-hemoglobinopathies across different genetic backgrounds
vol.33 iss.10 (2026) pp.13 Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease
vol.33 iss.10 (2026) pp.15 Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine
vol.33 iss.10 (2026) pp.18 Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease
vol.33 iss.10 (2026) pp.15 Endothelialized callus organoids drive rapid regeneration of critical-size segmental long bone defects
vol.33 iss.10 (2026) pp.18 Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases
vol.33 iss.10 (2026) pp.19 IGF2 acts downstream of Hippo signaling to regulate organ growth and restore liver regeneration in aging
vol.33 iss.10 (2026) pp.18 H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids
vol.33 iss.10 (2026) pp.20 Heart valves enter their organoid era
vol.33 iss.9 (2026) pp.2 APOE4 astrocytes call the shots on neuronal α-synuclein pathology
vol.33 iss.9 (2026) pp.3 Beyond compensation: Organized pathological hematopoiesis in the myelofibrotic spleen
vol.33 iss.9 (2026) pp.3 Feeling the tension: Engineered stem cells convert tumor stiffness into a drug target
vol.33 iss.9 (2026) pp.3 Ovarian aging and systemic health: Mechanisms and emerging intervention strategies
vol.33 iss.9 (2026) pp.18 Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types
vol.33 iss.9 (2026) pp.15 Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target
vol.33 iss.9 (2026) pp.18 Splenic extramedullary hematopoiesis in myelofibrosis is shaped by transcriptomic and epigenetic dysregulation
vol.33 iss.9 (2026) pp.19 Human iPSC-derived heart valve-like assembloids model valve development and disease pathology
vol.33 iss.9 (2026) pp.14 Human heart valve-like tissues from pluripotent stem cells with enhanced maturation recapitulate inflammatory valve disease
vol.33 iss.9 (2026) pp.12 Morphogen-guided neocortical organoids with anteroposterior areal identity
vol.33 iss.9 (2026) pp.13 TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation
vol.33 iss.9 (2026) pp.14 A Linc1405/Eomes Complex Promotes Cardiac Mesoderm Specification and Cardiogenesis
vol.33 iss.9 (2026) pp.1 “Heart-in-the-dish” models identify mechanisms of diastolic dysfunction
vol.33 iss.8 (2026) pp.3 The price of plasticity: Losing colon identity to gain metastatic potential
vol.33 iss.8 (2026) pp.3 Reconstructing primate gametogenesis along its developmental trajectory
vol.33 iss.8 (2026) pp.3 Mapping cell fate in space and time
vol.33 iss.8 (2026) pp.2 Living therapeutic depots: Matching design to therapeutic needs
vol.33 iss.8 (2026) pp.3 Dissecting divergent outcomes in stem cell-derived dopamine cell therapy trials for Parkinson’s disease
vol.33 iss.8 (2026) pp.13 Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis
vol.33 iss.8 (2026) pp.19 Generation of spermatogonia from human and non-human primate pluripotent stem cells
vol.33 iss.8 (2026) pp.15 Lineage plasticity driven by GATA6 loss fuels colorectal cancer metastasis
vol.33 iss.8 (2026) pp.20 Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
vol.33 iss.8 (2026) pp.15 Human iPSC-derived engineered heart tissue model of diastolic dysfunction in heart failure with preserved ejection fraction
vol.33 iss.8 (2026) pp.15 FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function
vol.33 iss.8 (2026) pp.9 Cardiopedia-Ligand: A ligand-receptor perturbation atlas of human cardiac organoid function and transcriptional state
vol.33 iss.8 (2026) pp.16 Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level
vol.33 iss.8 (2026) pp.19 SPACE-seq integrates spatial transcriptomics and lineage tracing in native tissues
vol.33 iss.8 (2026) pp.16 Evolving strategies for lineage tracing: Genetic markers, synthetic barcodes, and natural variants
vol.33 iss.7 (2026) pp.18 Designing complex organoids through developmental principles
vol.33 iss.7 (2026) pp.14 ENPP1 blockade with a humanized monoclonal antibody enhances renal repair after acute kidney injury
vol.33 iss.7 (2026) pp.17 Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment
vol.33 iss.7 (2026) pp.17 Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems
vol.33 iss.7 (2026) pp.17 Human retinal organoids functionally bridge a transected optic nerve in a rat model
vol.33 iss.7 (2026) pp.13 Generation of human appetite-regulating neurons and tanycytes from pluripotent stem cells
vol.33 iss.7 (2026) pp.17 ZNF512B safeguards genome integrity at regulatory regions to repress the SASP and inflammation
vol.33 iss.7 (2026) pp.14 Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation
vol.33 iss.7 (2026) pp.20 A precision product framework for context-dependent mechanisms of MSC therapy
vol.33 iss.6 (2026) pp.6 Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction
vol.33 iss.6 (2026) pp.17 Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation
vol.33 iss.6 (2026) pp.15 Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems
vol.33 iss.6 (2026) pp.19
